Publication date: Available online 6 October 2023
Source: Cancer Letters
Author(s): Giulia Bravetti, Paolo Falvo, Giovanna Talarico, Stefania Orecchioni, Francesco Bertolini
Category Archives: Cancer Letters
<em>ITPR1-AS1</em> promotes small cell lung cancer metastasis by facilitating <em>P21</em><sup><em>HRAS</em></sup> splicing and stabilizing DDX3X to activate the cRaf-MEK-ERK cascade
Publication date: Available online 9 October 2023
Source: Cancer Letters
Author(s): Quanli Zhang, Limin Zheng, Yongkang Bai, Chi Su, Yuru Che, Jiawen Xu, Kemin Sun, Jie Ni, Lingli Huang, Ye Shen, Lili Jia, Lin Xu, Rong Yin, Ming Li, Jingwen Hu
Editorial Board
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s):
Skin cancer prevention – Recent advances and unmet challenges
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Mahsa Mortaja, Shadmehr Demehri
Epigenetic regulation of pyroptosis in cancer: Molecular pathogenesis and targeting strategies
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Ruo-Nan Zhang, Zhi-Qian Jing, Lu Zhang, Zhi-Jun Sun
EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Qiang Ma, Yijian Zhang, Haibin Liang, Fei Zhang, Fatao Liu, Shili Chen, Yunping Hu, Lin Jiang, Yajuan Hao, Maolan Li, Yingbin Liu
Inflammatory cytokine-regulated <em>LNCPTCTS</em> suppresses thyroid cancer progression via enhancing Snail nuclear export
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Chi Ma, Nasha Zhang, Teng Wang, Haixia Guan, Yizhou Huang, Linying Huang, Yanxiu Zheng, Long Zhang, Linyu Han, Yanfei Huo, Yanting Yang, Haitao Zheng, Ming Yang
Cooperation between IRTKS and deubiquitinase OTUD4 enhances the SETDB1-mediated H3K9 trimethylation that promotes tumor metastasis via suppressing E-cadherin expression
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Xiaofang Cui, Xueying Shang, Jia Xie, Chenyi Xie, Zhanyun Tang, Qing Luo, Chongchao Wu, Guangxing Wang, Na Wang, Kunyan He, Lan Wang, Liyu Huang, Bingbing Wan, Robert G. Roeder, Ze-Guang Han
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Prabhakar Pitta Venkata, Sridharan Jayamohan, Yi He, Salvador Alejo, Jessica D. Johnson, Bridgitte E. Palacios, Uday P. Pratap, Yihong Chen, Zexuan Liu, Yi Zou, Zhao Lai, Takayoshi Suzuki, Suryavathi Viswanadhapalli, Susan T. Weintraub, Srinath Palakurthi, Philip T. Valente, Rajeshwar R. Tekmal, Edward R. Kost, Ratna K. Vadlamudi, Gangadhara R. Sareddy
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Zhangyi Luo, Katherine M. Eichinger, Anju Zhang, Song Li